AlphaCentric Advisors’s Tectonic Therapeutic TECX Stock Holding History
Bought
Maintained
Sold
Other funds holding TECX
AlphaCentric Advisors's TECX Position: Q3 2026 in Review
AlphaCentric Advisors increased its Tectonic Therapeutic (TECX) stake by 3.1% in Q3 2026, buying an estimated $6.67K and bringing the position to 7,161 shares worth $167K. The position accounts for 0.15% of the portfolio, ranked #168.
AlphaCentric Advisors first reported a position in TECX in Q4 2020 and has held it in 5 quarters since. The position peaked at $247K in Q4 2020. 87 funds tracked by Wall St. Rank hold TECX as of Q3 2026.
- AlphaCentric Advisors held 7,161 shares of Tectonic Therapeutic worth $167K as of Q3 2026.
- AlphaCentric Advisors bought 213 Tectonic Therapeutic shares in Q3 2026, an estimated $6.67K.
- Tectonic Therapeutic made up 0.15% of AlphaCentric Advisors's portfolio in Q3 2026, its #168 holding.
- AlphaCentric Advisors first reported a position in Tectonic Therapeutic in Q4 2020 and has held it in 5 quarters since.
- AlphaCentric Advisors's Tectonic Therapeutic position peaked at $247K in Q4 2020.
- 87 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2026.
Based on AlphaCentric Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.